YahooSeptember 7, 2026 at 10:27 PM NYLast Month
Altimmune’s (ALT) Three Liver Trials Move Forward At Once
On August 12, Altimmune (NASDAQ:ALT) reported second quarter results that read less like a routine earnings update and more like a status check on three separate diseases at the same time. The clinical-stage biopharmaceutical company disclosed a newly launched global Phase 3 trial in MASH, positive Phase 2 data in alcohol use disorder, and completed […]
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
